Kenvue Valuation

Is KVUE undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of KVUE when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: KVUE ($21.51) is trading below our estimate of fair value ($33.4)

Significantly Below Fair Value: KVUE is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for KVUE?

Key metric: As KVUE is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for KVUE. This is calculated by dividing KVUE's market cap by their current earnings.
What is KVUE's PE Ratio?
PE Ratio38.8x
EarningsUS$1.06b
Market CapUS$42.26b

Price to Earnings Ratio vs Peers

How does KVUE's PE Ratio compare to its peers?

The above table shows the PE ratio for KVUE vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average59.5x
EL Estée Lauder Companies
132.6x36.0%US$28.1b
BRBR BellRing Brands
39.4x12.0%US$9.9b
COTY Coty
38.6x23.0%US$6.4b
IPAR Interparfums
27.4x7.9%US$4.3b
KVUE Kenvue
38.8x20.8%US$42.3b

Price-To-Earnings vs Peers: KVUE is good value based on its Price-To-Earnings Ratio (38.8x) compared to the peer average (59.5x).


Price to Earnings Ratio vs Industry

How does KVUE's PE Ratio compare vs other companies in the US Personal Products Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
NEPT.F Neptune Wellness Solutions
n/an/aUS$98.52k
No more companies available in this PE range
KVUE 38.8xIndustry Avg. 28.4xNo. of Companies5PE020406080100+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: KVUE is expensive based on its Price-To-Earnings Ratio (38.8x) compared to the North American Personal Products industry average (28.4x).


Price to Earnings Ratio vs Fair Ratio

What is KVUE's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

KVUE PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio38.8x
Fair PE Ratio40.1x

Price-To-Earnings vs Fair Ratio: KVUE is good value based on its Price-To-Earnings Ratio (38.8x) compared to the estimated Fair Price-To-Earnings Ratio (40.1x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst KVUE forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$21.51
US$24.64
+14.5%
7.1%US$27.00US$21.00n/a15
Dec ’25US$24.08
US$24.68
+2.5%
7.9%US$27.00US$21.00n/a14
Nov ’25US$22.73
US$23.99
+5.5%
7.9%US$27.00US$21.00n/a14
Oct ’25US$22.78
US$23.05
+1.2%
9.7%US$27.00US$18.00n/a15
Sep ’25US$21.95
US$22.49
+2.4%
9.3%US$26.00US$18.00n/a14
Aug ’25US$18.63
US$21.88
+17.4%
10.1%US$25.50US$18.00n/a14
Jul ’25US$17.95
US$22.54
+25.6%
9.4%US$25.50US$18.00n/a14
Jun ’25US$19.30
US$22.54
+16.8%
9.4%US$25.50US$18.00n/a14
May ’25US$18.85
US$22.44
+19.0%
9.7%US$25.50US$18.00n/a15
Apr ’25US$21.23
US$22.79
+7.3%
8.6%US$25.50US$20.00n/a14
Mar ’25US$18.82
US$22.79
+21.1%
8.6%US$25.50US$20.00n/a14
Feb ’25US$20.89
US$24.43
+16.9%
7.5%US$27.50US$21.00n/a14
Jan ’25US$21.53
US$24.36
+13.1%
8.7%US$27.50US$20.00n/a14
Dec ’24US$20.69
US$23.96
+15.8%
10.9%US$27.50US$20.00US$24.0813
Nov ’24US$18.88
US$24.71
+30.9%
10.5%US$28.00US$20.00US$22.7312
Oct ’24US$20.08
US$27.86
+38.8%
4.5%US$30.00US$26.00US$22.7811
Sep ’24US$22.96
US$27.85
+21.3%
4.7%US$30.00US$26.00US$21.9510
Aug ’24US$23.65
US$27.85
+17.8%
4.7%US$30.00US$26.00US$18.6310
Jul ’24US$26.42
US$28.25
+6.9%
3.3%US$30.00US$27.00US$17.9510
Jun ’24US$25.28
US$28.33
+12.1%
3.3%US$30.00US$27.00US$19.309

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/18 22:29
End of Day Share Price 2024/12/18 00:00
Earnings2024/09/29
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Kenvue Inc. is covered by 20 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ishan MajumdarBaptista Research
Lauren LiebermanBarclays
Navann Ty DietschiBNP Paribas Exane